‘Smelling’ Prostate Cancer A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.Criminal Justice Alcohol Program Linked to Decreased Mortality Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Individuals' Medical Histories Predicted by their Noncoding Genomes Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.'Molecular Movie' Opens Door to New Cancer Treatments An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.Advancing Synthetic Biology Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.Preparing for Potential Zika Outbreaks Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection. What do Banana Peels and Human Skin Have in Common? Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer. Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Lab-on-Chip Platform Technologies for Point-of-Care Testing and Cell Culturing This presentation focuses on recent advances in platform technologies developed at Micronit for applications within point-of-care diagnostics and cell culturing. A few examples developed within research projects are presented to illustrate the applicability of the developed technologies.
Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Next-generation POC Devices for Western and Global Health Markets Samuel Sia, Columbia University, speaking at Point of Care Diagnostics 2015
"Lab-in-a-hanky" - What Comes Next after Lab-on-a-Chip Frank Bier, University of Potsdam / Fraunhofer IZI-BB, speaking at Point of Care Diagnostics 2015
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit Kevin Cox, Imanova Limited, speaking at Diagnostics & Biomarkers.
Cardiac Point of Care – Current Technology and Future Directions Paul Collinson, St Georges Healthcare NHS Trust, speaking at Point of Care Diagnostics 2015
Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication Richard Murdock, USAF, speaking at Point of Care Diagnostics 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
The Application of a Resonant Coil Magnetometer for Point of Care Diagnostic Applications Richard Luxton, University of the West of England, speaking at Point of Care Diagnostics 2015